Tudor Investment Corp’s BioNTech BNTX Stock Holding History

Tudor Investment Corp’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$690K	Buy	7,758 +4,801	+162%	+$493K	﹤0.01%	2614
2025 Q4	$282K	Buy	+2,957	New	+$298K	﹤0.01%	3093
2023 Q4	–	Sell	-2,934	Closed	-$319K	–	2389
2023 Q3	$319K	Buy	+2,934	New	+$324K	﹤0.01%	1904
2023 Q1	–	Sell	-5,123	Closed	-$770K	–	2426
2022 Q4	$770K	Buy	+5,123	New	+$788K	0.02%	1297
2022 Q3	–	Sell	-2,257	Closed	-$337K	–	2316
2022 Q2	$337K	Buy	+2,257	New	+$345K	0.01%	1489
2021 Q4	–	Sell	-1,853	Closed	-$506K	–	2409
2021 Q3	$506K	Buy	+1,853	New	+$589K	0.01%	1639
2021 Q2	–	Sell	-5,046	Closed	-$551K	–	1617
2021 Q1	$551K	Buy	+5,046	New	+$536K	0.01%	1103

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tudor Investment Corp's BNTX Position: Q1 2026 in Review

Tudor Investment Corp increased its BioNTech (BNTX) stake by 162% in Q1 2026, buying an estimated $493K and bringing the position to 7,758 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #2614.

Tudor Investment Corp first reported a position in BNTX in Q1 2021 and has held it in 7 quarters since. The position peaked at $770K in Q4 2022. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Tudor Investment Corp held 7,758 shares of BioNTech worth $690K as of Q1 2026.
Tudor Investment Corp bought 4,801 BioNTech shares in Q1 2026, an estimated $493K.
BioNTech made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2614 holding.
Tudor Investment Corp first reported a position in BioNTech in Q1 2021 and has held it in 7 quarters since.
Tudor Investment Corp's BioNTech position peaked at $770K in Q4 2022.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.